Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | FBIO Fortress Biotech, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $2.53 +0.2% | $16.48 +2.3% |
| StockIQ Score | 49D+ Moderate Risk: High | 35F Weak Risk: High |
| Technical | 16F | 13F |
| Fundamental | 49D+ | 35F |
| Growth | 68B- | 50C- |
| Fair Value | 50C- | 38F |
| News | 92A+ | 50C- |
| Quality | 58C | 50C- |
| Risk | 40D | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Fortress Biotech (FBIO) outperforms Ascentage Pharma (AAPG) in every reported score. FBIO’s investor, technical, fundamental, growth and valuation scores are 49, 16, 49, 68 and 50, compared with AAPG’s 35, 13, 35, 50 and 38. The biggest gap appears in growth (68 vs 50). FBIO’s rating is MODERATE versus AAPG’s WEAK.
